Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

28.06 +0.20 (+0.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
18 19 Next >
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
From QuidelOrtho Corporation
Via Business Wire
Analyst Expectations for QuidelOrtho's Future
 
Via Benzinga
Earnings Scheduled For February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. 
Via Benzinga
Earnings Preview For QuidelOrtho
 
Via Benzinga
QuidelOrtho to Participate in the Evercore ISI Conference
From QuidelOrtho Corporation
Via Business Wire
Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report
QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm. 
Via Benzinga
QuidelOrtho Reports Third Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core Profitability: Analyst
QuidelOrtho Corporation (NASDAQ: QDEL) released preliminary Q3 revenue of $738 million to $744 million, primarily driven by higher respiratory product sales,  
Via Benzinga
Where QuidelOrtho Stands With Analysts
 
Via Benzinga
QuidelOrtho's Return on Invested Capital Overview
 
Via Benzinga
QuidelOrtho: Q1 Earnings Insights
 
Via Benzinga
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
Analyst Is Frustrated By QuidelOrtho's Reduction In Guidance - Here's Why
Raymond James analyst Andrew Cooper reiterates Strong Buy on QuidelOrtho Corporation (NASDAQ: QDEL),  
Via Benzinga
QuidelOrtho Reports Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Report Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Market Mixes It Up With A Broad Rally
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
Via Talk Markets
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
From QuidelOrtho Corporation
Via Business Wire
Something Happened In Biotech Last Week
Biotech stocks were more constructive last week with some sharp moves up. 
Via Talk Markets
QuidelOrtho Reports First Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro... 
Via Talk Markets
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.